Search Results

The Effect of Potentially Hepatotoxic Medicinal Products on Alanine Transaminase Levels in COVID-19 Patients: A Case–Control Study

• Authors : V. I. Petrov; A. Yu. Ryazanova; N. S. Tokareva

Subjects: drug-induced liver injury; rucam scale; covid-19

• Source: Безопасность и риск фармакотерапии, Vol 13, Iss 2, Pp 172-183 (2025)

Record details

The Association Between Aspartate Transaminase to Alanine Transaminase Ratio and Perioperative Ischemic Stroke in Patients With Diabetes: A Retrospective Cohort Study.

• Authors : Liu S; Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.; National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.

Subjects: Ischemic Stroke*/Ischemic Stroke*/Ischemic Stroke*/blood ; Ischemic Stroke*/Ischemic Stroke*/Ischemic Stroke*/diagnosis ; Ischemic Stroke*/Ischemic Stroke*/Ischemic Stroke*/epidemiology

• Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2025 Jan; Vol. 31 (1), pp. e70223.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print Cited Medium: Internet ISSN: 1755-5949

Record details

Nucleos(t)ide analogs to treat patients with positive hepatitis B virus deoxyribonucleic acid and normal alanine transaminase: protocol for an open-label single-center randomized parallel controlled trial.

• Authors : Zhou J; Center of Infectious Diseases, West China Hospital, Sichuan University, No.37 Guo Xue Xiang, Wuhou District, Chengdu, 610041, China.; Wang FD

Subjects: Hepatitis B virus*/Hepatitis B virus*/Hepatitis B virus*/genetics ; Hepatitis B virus*/Hepatitis B virus*/Hepatitis B virus*/drug effects ; Alanine Transaminase*/Alanine Transaminase*/Alanine Transaminase*/blood

• Source: Trials [Trials] 2024 Oct 03; Vol. 25 (1), pp. 652. Date of Electronic Publication: 2024 Oct 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

Record details

Lower HBV DNA level is associated with more severe liver fibrosis in HBeAg-positive chronic hepatitis B with normal alanine transaminase.

• Authors : Wang J; Department of Infectious Diseases, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, No. 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.; Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu, China.

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/complications ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/virology ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/pathology

• Source: Virology journal [Virol J] 2024 Jun 04; Vol. 21 (1), pp. 127. Date of Electronic Publication: 2024 Jun 04.Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X

Record details

Evaluation of Serum Alanine Transaminase Levels in Children with Type 1 Diabetes Mellitus: A Cross-Sectional Study.

• Authors : B. E., Pavithra Shree¹; N. S., Yashwanth²; D. A., Divyashree

• Source: European Journal of Cardiovascular Medicine. Apr2025, Vol. 15 Issue 4, p848-851. 4p.

Record details

Alanine transaminase and hemoglobin appear to predict the occurrence of antituberculosis medication hepatotoxicity; findings and implications in Botswana

• Authors : Kesenogile, B; Godman, B; Rwegerera, GM

Subjects: Medicin och hälsovetenskap; Medicinska och farmaceutiska grundvetenskaper; Farmakologi och toxikologi

• Source: Expert review of anti-infective therapy. 19(3):379-391

Record details

Efek Ekstrak Ciplukan (Physalis angulata L.) terhadap Kadar Alanine Transaminase (ALT) Tikus Model Diabetes Melitus

• Authors : IDZNI, Farisah

Subjects: D146 Diabetes; Thesis; NonPeerReviewed

Record details

Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy).

• Authors : Scullion KM; Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK.; MacIntyre IM

Subjects: Acetaminophen* ; Cross-Over Studies* ; Alanine Transaminase*/Alanine Transaminase*/Alanine Transaminase*/blood

• Source: Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2024 May 28; Vol. 199 (2), pp. 203-209.Publisher: Oxford University Press Country of Publication: United States NLM ID: 9805461 Publication Model: Print Cited Medium: Internet ISSN:

Record details

HUBUNGAN KADAR ANTIBODI HCV DENGAN ASPARTATE TRANSAMINASE DAN ALANINE TRANSAMINASE PADA PASIEN HEPATITIS C: RELATIONSHIP OF HCV ANTIBODY LEVELS WITH ASPARTATE TRANSAMINASE AND ALANINE TRANSAMINASE IN HEPATITIS C PATIENTS

• Authors : null Ni Nyoman Suardani; null I Made Sumarya; null I Nyoman Arsana

• Source: JURNAL WIDYA BIOLOGI. 15:73-77

Record details

Which of the following tests aspartate aminotransferase, alanine transaminase and alkaline phosphatase, can predict poor outcomes in Coronavirus 2019 patients? a retrospective cohort study

• Authors : Pouyan Ebrahimi; AmirHossein Nasiri-Valikboni; Mahmoud Sadeghi Haddad Zavareh

Subjects: covid-19; aspartate aminotransferase; alkaline phosphatase

• Source: Journal of Kerman University of Medical Sciences, Vol 31, Iss 2, Pp 98-103 (2024)

Record details